The serological response of chickens to oil emulsion vaccines containing the V4 strain of Newcastle disease virus.
Experiments were conducted with vaccines containing the V4 strain of Newcastle disease virus (NDV). Both living aqueous vaccines and vaccines consisting of virus incorporated oil emulsion were used. The calculated dose of virus contained in the oil emulsion vaccine was 10(8.7) 50% embryo infectious doses (EID50) per bird dose. Haemagglutinin inhibition (HI) antibody levels of 8 are presumed protective. One-day-old chicks with low levels of maternal antibody were vaccinated intraocularly with 10(6.3)EID50 ol live vaccine, and concurrently with oil emulsion vaccine. Presumed protective levels of antibody were present at two weeks post vaccination and were maintained for at least seven weeks longer. When adult birds 15 weeks old with no previous exposure to NDV were vaccinated intraocularly with 10(6.7)EID50 per bird, protective levels of antibody were produced within a week. Unvaccinated birds put in contact with the vaccinated birds produced similar antibody levels within 14 days. Revaccination with oil emulsion vaccine after antibody levels had fallen resulted in a rapid response with high levels of antibody. When antibody-free adult commercial birds with an unknown history of exposure to NDV were vaccinated intramuscularly with oil emulsion vaccine, high antibody levels were produced for at least 21 weeks. Concurrent intraocular inoculation with 10(7.0)EID50 live virus did not enhance the response. Natural infection of unvaccinated birds occurred during the experiment. This was detected by the presence of HI antibody levels of short duration. When antibody-free commercial birds were inoculated intramuscularly with oil emulsion vaccine containing 10(6.0), 10(7.0), or 10(8.0)EID50 per bird dose, 100% of birds inoculated with the highest dose produced presumed protective levels of antibody within two weeks, as compared with a 5-week delay when using the 10(7.0)EID50 per bird dose.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis*; D002645:Chickens / Q000276:immunology*; D004655:Emulsions; D005260:Female; D006385:Hemagglutination Inhibition Tests / Q000662:veterinary; D009521:Newcastle Disease / Q000517:prevention & control*; D009522:Newcastle disease virus / Q000276:immunology*; D009821:Oils; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D004655:Emulsions; D009821:Oils; D014613:Vaccines, Attenuated; D014765:Viral Vaccines